Puretech founded entity vor biopharma announces vor33 granted u.s. fda fast track designation for acute myeloid leukemia

Boston--(business wire)--puretech founded entity vor biopharma announced that the u.s. food and drug administration has granted fast track designation to vor33.

PRTC Ratings Summary

PRTC Quant Ranking